Steven R Davis

This inventor holds 20 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Human Milk Oligosaccharides. Top assignee: Abbott Laboratories Corporation. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven R Davis. Retrieved from https://idiyas.com/inventor/steven-r-davis-senajf07

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 6)

% Patents Active = 85.0

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 105(Granted Patents)

Location History:

Columbus, OH (US) (2014 - 2022)
Galena, OH (US) (2016 - 2023)

Company Filing History:

20 out of 4,188

Abbott Laboratories Corporation

patents

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

Human Milk Oligosaccharides

Respiratory Health

Gastrointestinal Healing

Oxidative Stress

Beneficial Bacteria

Acute Allergic Responses

Mucosal Innate Immunity

Nutrient Absorption

Necrotizing Enterocolitis

Colic

Short Bowel Syndrome

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12343355 - Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides (2025-07-01),

2. 12280069 - Methods of using human milk oligosaccharides for improving airway respiratory health (2025-04-21),

3. 11690859 - Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides (2023-07-04),

4. 11446316 - Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract (2022-09-20),

5. 11337990 - Human milk oligosaccharides to promote growth of beneficial bacteria (2022-05-24),

6. 11311562 - Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents (2022-04-26),

7. 11207335 - Methods of using human milk oligosaccharides for improving airway respiratory health (2021-12-28),

8. 11179406 - Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides (2021-11-23),

9. 11135233 - Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides (2021-10-05),

10. 10792294 - Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides (2020-10-06),

11. 10639319 - Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract (2020-05-05),

12. 10568896 - Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides (2020-02-25),

13. 10471081 - Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides (2019-11-12),

14. 9795623 - Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin C and anti-inflammatory agents (2017-10-24),

15. 9539269 - Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides (2017-01-10),

Title: Innovations by Steven R. Davis in Pediatric Nutrition

Introduction

Steven R. Davis, located in Columbus, OH, is a distinguished inventor with a remarkable portfolio of 19 patents. His work primarily focuses on advancing pediatric nutrition, particularly through the use of human milk oligosaccharides. Davis's innovative contributions aim to enhance the health and well-being of infants and children.

Latest Patents

Among his latest patents, Davis has developed methods utilizing human milk oligosaccharides to improve airway respiratory health. These nutritional compositions are designed for administration to preterm infants, term infants, toddlers, and children, enhancing their airway defense mechanisms. Additionally, he has patented methods for reducing the incidence of necrotizing enterocolitis in infants, toddlers, or children. These methods leverage nutritional compositions that include human milk oligosaccharides, demonstrating effectiveness in reducing inflammation and the occurrence of inflammatory diseases.

Career Highlights

Davis holds a prominent position at Abbott Laboratories Corporation, a well-respected company known for its commitment to health and nutrition solutions. His innovative work not only contributes to the corporate goals of Abbott but also significantly enhances the scientific community's understanding of pediatric dietary needs.

Collaborations

Throughout his career, Steven R. Davis has collaborated with accomplished peers, including Rachael Buck and Geralyn O. Duska-McEwen. These collaborations have fostered innovation and expanded the impact of their research in the field, combining expertise to address critical health issues affecting children.

Conclusion

Steven R. Davis exemplifies the spirit of innovation in pediatric nutrition with his significant contributions in the form of patents and collaborative research. His work paves the way for improved health outcomes in infants and young children, establishing him as a vital figure in the realm of nutritional science and invention. As advancements continue to unfold, his dedication to enhancing respiratory health and reducing inflammatory diseases will remain impactful.

Profile summary based on public USPTO records.